Respiratory Medicine
-
A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19
This article has 16 authors:Reviewed by ScreenIT
-
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis
This article has 7 authors:Reviewed by ScreenIT
-
Clinical characteristics and outcomes of adult patients admitted with COVID-19 in East London: a retrospective cohort analysis
This article has 4 authors:Reviewed by ScreenIT
-
The impact of COVID‐19 upon the delivery of exercise services within cystic fibrosis clinics in the United Kingdom
This article has 5 authors:Reviewed by ScreenIT
-
Endogenous IFNβ expression predicts outcome in critical patients with COVID-19
This article has 5 authors:Reviewed by ScreenIT
-
Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis
This article has 9 authors:Reviewed by ScreenIT
-
Smoking modulates different secretory subpopulations expressing SARS-CoV-2 entry genes in the nasal and bronchial airways
This article has 22 authors:Reviewed by ScreenIT
-
Evaluation of the ROX index in SARS-CoV-2 Acute Respiratory failure treated with both High-Flow Nasal Oxygen (HFNO) and Continuous Positive Airway Pressure (CPAP)
This article has 12 authors:Reviewed by ScreenIT
-
The herbal combination of Sugarcane, Black Myrobalan, and mastic as a supplementary treatment for COVID-19: a randomized clinical trial
This article has 7 authors:Reviewed by ScreenIT
-
Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length
This article has 9 authors:Reviewed by ScreenIT